Esther Rajavelu - Chief Financial Officer and Chief Business Officer at Spero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer and Chief Business Officer
Stock Symbol
SPRO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Esther Rajavelu since 9/11/2023

Holdings reported by Esther Rajavelu for Spero Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 420K $609K $1.45 Feb 1, 2024 Direct

Transactions reported by Esther Rajavelu for Spero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.